About Azienda Ospedaliero Universitaria S.Maria della Misericordia - Gastroenterologia
Top Sponsors
Top Collaborators
Trials By Phase
Recruitment Status
Top Conditions
Intervention Types
Top Intervention Names
Trials By Gender
Lead Sponsor
# Trials
Eli Lilly and Company
2
Takeda
1
Tigenix S.A.U.
1
Clinical Trials at Azienda Ospedaliero Universitaria S.Maria della Misericordia - Gastroenterologia
During the past decade, Azienda Ospedaliero Universitaria S.Maria della Misericordia - Gastroenterologia conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 2 clinical trials were completed, i.e. on
average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Study to Assess Efficacy and Safety of Cx601, Adult Allogeneic Expanded Adipose-derived Stem Cells (eASC) for the Treatment of Complex Perianal Fistula(s) in Participants With Crohn's Disease (CD)
Long-term Follow-up Study With Darvadstrocel in the Treatment of Complex Perianal Fistula
2019-11-04
2024-03-28
Active, not recruiting
151
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at Azienda Ospedaliero Universitaria S.Maria della Misericordia - Gastroenterologia
According to Clinical.Site data, the most researched conditions in "Azienda Ospedaliero Universitaria S.Maria della Misericordia - Gastroenterologia" are
"Crohn's Disease" (2 trials), "Ulcerative Colitis" (2 trials) and "Complex Perianal Fistula" (1 trials). Many other conditions were trialed in "Azienda Ospedaliero Universitaria S.Maria della Misericordia - Gastroenterologia" in a lesser frequency.
Clinical Trials Intervention Types at Azienda Ospedaliero Universitaria S.Maria della Misericordia - Gastroenterologia
Most popular intervention types in "Azienda Ospedaliero Universitaria S.Maria della Misericordia - Gastroenterologia" are "Drug" (3 trials), "Biological" (1 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (2 trials), "Cx601" (1 trials), "Darvadstrocel" (1 trials), "Mirikizumab" (1 trials) and "Mirikizumab IV" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Azienda Ospedaliero Universitaria S.Maria della Misericordia - Gastroenterologia
The vast majority of trials in "Azienda Ospedaliero Universitaria S.Maria della Misericordia - Gastroenterologia" are
4 trials for "All" genders.
Clinical Trials Status at Azienda Ospedaliero Universitaria S.Maria della Misericordia - Gastroenterologia
Currently, there are NaN active trials in "Azienda Ospedaliero Universitaria S.Maria della Misericordia - Gastroenterologia".
undefined are not yet recruiting,
1 are recruiting,
3 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were undefined completed trials in Azienda Ospedaliero Universitaria S.Maria della Misericordia - Gastroenterologia,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Azienda Ospedaliero Universitaria S.Maria della Misericordia - Gastroenterologia, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 4 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".